$NBIS

Nave Ophir sold $117.8M of NBIS

Nave Ophir (COO) sold 500,000 shares of Nebius Group N.V. (NBIS) at an average of $235.53 ($231.12–$243.50, $117.77M total) across 12 trades on 2026-10-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Nave Ophir
Published Oct 6, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Bearish
high confidence
Mentioned
$NBIS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISBearishMed
01

Why it matters

The disclosed $117.8M sale by a senior officer is likely to be interpreted as a negative signal by the market, prompting short‑term price decline.

02

Market read

First‑time disclosure of a large insider sell; traders may consider short positions or monitor price reaction.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the 10b5‑1 plan are not disclosed.

Relevance 6/10Novelty 8/10Timing: after-hours today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$NBISBearishHigh confidence
Context

Form 4 shows COO Nave Ophir sold $117.8M of NBIS shares via a 10b5‑1 plan, reducing his stake to 454,685 shares.

Expected impact

likely downward pressure as the market prices in the insider sale

Evidence & confidence

The sale size ($117.8M) is material for a mid‑cap stock and is disclosed for the first time via a primary SEC filing.

Market effects

Minimal; the sale is company‑specific and does not signal broader sector trends.

Limited to markets where NBIS trades; no wider regional effect.

Low; only relevant to investors holding NBIS.

Counterpoint

The sale may be a routine liquidity event unrelated to fundamentals, so price impact could be muted.

Key entities

  • Nebius Group N.V.

    Issuer of the shares sold in the Form 4 filing.

  • Nave Ophir

    Chief Operating Officer of Nebius Group N.V. and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.